Elevated NfL levels in the blood or CSF correlate with reduced cognitive function, advanced neurodegeneration, and rapid cognitive decline in patients with AD (Mattsson et al., 2019; Moscoso et al., 2021; Sugarman et al., 2020; Weston et al., 2017). Here, NEFL is linked to Alzheimer disease.